Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
TWIST1 (TW) is a bHLH transcription factor (TF) and master regulator of the epithelial‐to‐mesenchymal transition (EMT). In vitro, TW promotes mesenchymal change, invasion, and self‐renewal in glioblastoma (GBM) cells. However, the potential therapeutic relevance of TW has not been established throug...
Main Authors: | Andrei M. Mikheev, Svetlana A. Mikheeva, Liza J. Severs, Cory C. Funk, Lei Huang, José L. McFaline‐Figueroa, Jeanette Schwensen, Cole Trapnell, Nathan D. Price, Stephen Wong, Robert C. Rostomily |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12320 |
Similar Items
-
TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression
by: Svetlana A. Mikheeva, et al.
Published: (2019-09-01) -
Recombinant mouse periostin ameliorates coronal sutures fusion in Twist1+/− mice
by: Shanshan Bai, et al.
Published: (2018-04-01) -
Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
by: Fengyu Zhang, et al.
Published: (2020-07-01) -
First Report of Tumorigenic Agrobacterium radiobacter on Raspberry in Serbia
by: Svetlana Milijašević, et al.
Published: (2007-01-01) -
Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis
by: Li L, et al.
Published: (2018-10-01)